These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
4. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE. AUERSWALD W; DOLESCHEL W Med Exp Int J Exp Med; 1964; 10():179-84. PubMed ID: 14129855 [No Abstract] [Full Text] [Related]
5. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
6. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related]
7. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS. LEWIS JH; KERBER CW; WILSON JH Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447 [No Abstract] [Full Text] [Related]
8. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
9. THE QUANTITATIVE DETERMINATION OF FIBRINOLYTIC INHIBITORS IN PLASMA OR SERUM BY MEANS OF THE FIBRIN PLATE. BLIX S Scand J Clin Lab Invest; 1964; 16():403-8. PubMed ID: 14202020 [No Abstract] [Full Text] [Related]
10. FIBRINOGEN BREAKDOWN PRODUCTS. LEWIS JH; WILSON JH Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449 [No Abstract] [Full Text] [Related]
11. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD. BRAKMAN P; ASTRUP T Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193 [No Abstract] [Full Text] [Related]
12. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS. TSAPOGAS MJ Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330 [No Abstract] [Full Text] [Related]
13. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL. FLEMING LB; CLIFFTON EE J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210 [No Abstract] [Full Text] [Related]
14. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY]. SHIRAI T Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987 [No Abstract] [Full Text] [Related]
15. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. TODD AS Br Med Bull; 1964 Sep; 20():210-2. PubMed ID: 14209761 [No Abstract] [Full Text] [Related]
16. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
17. EFFECTS OF FIBRINOLYTIC AGENTS ON EXPERIMENTAL AND CLINICAL THROMBOSIS. TSAPOGAS MJ J Clin Pathol; 1964 May; 17(3):360-1. PubMed ID: 14159483 [No Abstract] [Full Text] [Related]